Nasdaq Biotech Decliners: Celsion Corp. (NASDAQ:CLSN) and Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) Added to Growing Stock Report's Nasdaq's Biotech Decliners Watch List

New York, NY -- (SBWIRE) -- 02/01/2013 -- Growing Stock Report adds Celsion Corp. (NASDAQ:CLSN) and Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) to their Nasdaq Biotech Decliners Watch List.

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States is currently down (-16.31%) after a massive run up this week. Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) rose (+250.18%) in just about a week from a daily low of $2.85 to an intra-day high of $9.98 in just a few days later. This speculation and run up may have caused today's sell off.

Click Here to find out what other Investors are saying about Keryx Biopharmaceuticals Inc.

Celsion Corp. (NASDAQ:CLSN) an oncology drug development company that engages in the development and commercialization of targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology is currently down (-13.91%) today, but also down (-86.33%) after hitting it's 52-week high of $9.44 just over 2 weeks ago, which has prompted Growing Stock Report to add Celsion Corp. (NASDAQ:CLSN) to their Nasdaq Biotech Decliners Watch List.

Click Here to find out what other Investors are saying about Celsion Corp.

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com